图书简介

1. General overview/introduction by co-editors, with a historical perspective; Section I. Ketogenic Diet for Epilepsy in the Clinic; 2. Overview: Ketogenic Diets and Pediatric Epilepsy: An Update; 3. ’Alternative’ Ketogenic Diets; 4. Ketogenic Diet Therapies in Adults: History, Demand, and Results; 5. How Do You Implement the Diet?; 6. Glut1 Deficiency Syndrome and the Ketogenic Dietary Therapies; 7. Ketogenic Diet in Established Epilepsy Indications; 8. Ketogenic Diet for Other Epilepsies; 9. The Ketogenic Diets in Idiopathic Generalized Epilepsy Syndromes; 10. Ketogenic Diet Therapy for Infants with Pharmacoresistant Epilepsy and/or Metabolic Disease; 11. Ketogenic Diet in Status Epilepticus; 12. Preventing Side Effects and Diet Discontinuation; Section II. Ketogenic Diet: Emerging Clinical Applications and Future Potential; 13. Overview: Expanded Uses of Ketogenic Therapies; 14. Metabolism-Based Treatments for Managing Cancer: Scientific Rationale; 15. Ketogenic Diet as Adjunctive Therapy for Malignant Brain Cancer; 16. Ketogenic Diet, Social Behavior, and Autism: Insights from Animal Models; 17. Ketotherapeutics to Rescue Brain Energy Deficits: An Emerging Strategy to Delay Cognitive Decline in Alzheimer’s Disease; 18. Ketogenic Diet and Ketones for Improving Neurological Outcomes after Acute Neurotrauma; 19. Ketogenic Diets and Neuroinflammation; 20. The Ketogenic Diet in the Treatment of Schizophrenia; 21. The Ketogenic Diet and the Gut Microbiome; Section III. Ketogenic Diet in the Laboratory; 22. Overview of Ketogenic Diet in the Laboratory: Progress on Models and Mechanisms; 23. Ketogenic Diet and PPARy; 24. Ketogenic Diet and Adenosine in Epilepsy - Models and Mechanisms; 25. Ketogenic Diet and Epigenetic Mechanisms of Epileptogenesis; 26. Ketogenic Diet, Aging, and Neurodegeneration; 27. Metabolic Seizure Resistance via BAD and KATP Channels; 28. Lactate Dehydrogenase: a Novel Metabolic Target; 29. Effects of the Ketogenic Diet on the Blood-Brain Barrier; 30. Metabolic and Redox Alterations by Ketogenic Diets; 31. Nicotinamide Adenine Dinucleotide as a Central Mediator of the Ketogenic therapy; Section IV. Ketone-Based Metabolism: General Health and Metabolic Alternatives; 32. Overview of Ketone-Based Metabolism: General Health and Metabolic Alternatives; 33. Ketone Supplementation for Health and Disease; 34. Neuroprotective and Behavioral Benefits of Exogenous Ketone Supplementation-evoked Ketosis; 35. Amino Acids in the Treatment of Neurological Disorders; 36. Identifying the Molecular Mechanism of the MCT (Ketogenic) Diet; 37. Triheptanoin in Epilepsy and Beyond; 38. Anti-seizure and Anti-epileptic Effects of Glycolysis Inhibition with 2-Deoxyglucose; 39. Low Carbohydrate, Ketogenic Diets for the Treatment of Type 2 Diabetes and Obesity; 40. Intermittent Exogenous Ketosis for Athletic Performance, Recovery and Adaptation; 41. Advancing the Awareness and Application of Metabolic and Ketogenic Therapies Globally and Offering Hope

Trade Policy 买家须知